The Vascular group thinks their feces doesn't emit a foul odor. As the previous poster pointed out, they've acquired some good things (VNUS, ev3, Bacchus) but they can't run them worth a damn. The Vascular group in Mansfield has always been put on a high perch but all they know are SCDs and dialysis catheters. This, coupled with the loss (or jettisoning) of legacy product knowledge from the acquired businesses has led to suboptimal results.
That said, it’s probably one of the best divisions to be in. It’s well-funded and many higher-ups have a vested interest in seeing it succeed. It’s certainly the highest profile Kendall division and it may even be less of a fiasco than what’s going on at North Haven (re-re-re-re-innovating mesh and staplers). The products are good but keep in mind that few of those setting targets and plans have any idea how to sell them. You’d better be good on your own merits because you’re not going to get a lot of clear guidance from the mother ship.
